Over-expression of P2X7 receptors in spinal glial cells contributes to the development of chronic postsurgical pain induced by skin/muscle incision and retraction (SMIR) in rats

Exp Neurol. 2014 Nov:261:836-43. doi: 10.1016/j.expneurol.2014.09.007. Epub 2014 Sep 19.

Abstract

Many patients suffer from chronic postsurgical pain (CPSP) following surgery, and the underlying mechanisms are poorly understood. In the present work, with use of the skin/muscle incision and retraction (SMIR) model, the role of P2X7 receptors (P2X7Rs) in spinal glial cells in the development of CPSP was evaluated. Consistent with previous reports, we found that SMIR decreased the ipsilateral 50% paw withdrawal threshold (PWT), lasting for at least 2weeks. No injury was done to L3 dorsal root ganglia (DRG) neurons and no axonal or Schwann cell damage at the retraction site in the saphenous nerve was observed 7days after SMIR. The results of immunofluorescence showed that both microglia and astrocytes were activated in the spinal dorsal horn following SMIR. In addition, both P2X7Rs and tumor necrosis factor-alpha (TNF-α) were up-regulated following SMIR. Double immunofluorescence staining revealed that the up-regulated P2X7R immunoreactivity was mainly located in microglia, and to a lesser extent in astrocytes, but not in neurons. Intrathecal delivery of specific P2X7R antagonist BBG (10μM in 10μl volume) or A438079 (10μM in 10μl volume), started 30min before the surgery and once daily thereafter for 7days, prevented the mechanical allodynia. Intrathecal injection of BBG inhibited the activation of microglia and astrocytes, and the up-regulation of TNF-α induced by SMIR. These data suggest that P2X7Rs in the spinal dorsal horn might mediate the development of CPSP via activation of glial cells and up-regulation of TNF-α.

Keywords: Chronic postsurgical pain; Microglia; P2X7 receptor; Tumor necrosis factor-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dermatologic Surgical Procedures / adverse effects
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Functional Laterality
  • Glial Fibrillary Acidic Protein / metabolism
  • Male
  • Microscopy, Electron, Transmission
  • Muscles / surgery
  • Neuroglia / metabolism*
  • Neuroglia / ultrastructure
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / etiology
  • Pain, Postoperative / pathology*
  • Purinergic P2X Receptor Antagonists / therapeutic use
  • Pyridines / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X7 / metabolism*
  • Skin
  • Spinal Cord / pathology*
  • Tetrazoles / therapeutic use
  • Time Factors
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine
  • Glial Fibrillary Acidic Protein
  • Purinergic P2X Receptor Antagonists
  • Pyridines
  • Receptors, Purinergic P2X7
  • Tetrazoles